New Developments in Liposomal Drug Delivery

Chemical Reviews

Volumn 115, Issue 19, 2015, Pages 10938-10966

  Pattni, Bhushan S ^a   Chupin, Vladimir V ^b   Torchilin, Vladimir P ^a,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; FATTY ACIDS; LIPOSOMES; LIQUID CHROMATOGRAPHY; MEDICINE; NUCLEIC ACIDS; PHOSPHOLIPIDS; PROTEINS; VACCINES;

BATCH-TO-BATCH REPRODUCIBILITY; EXOTIC MATERIALS; IMMOBILIZED LIPOSOME CHROMATOGRAPHIES; PHOSPHATIDYLSERINE; PROTEIN SEPARATIONS; SMALL-MOLECULE DRUGS; STABILITY PROBLEM; STATIONARY PHASE;

DRUG DELIVERY;

DRUG; DRUG CARRIER; LIPOSOME;

ANIMAL; CHEMISTRY; HUMAN;

ANIMALS; DRUG CARRIERS; HUMANS; LIPOSOMES; PHARMACEUTICAL PREPARATIONS;

EID: 84941763546     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/acs.chemrev.5b00046     Document Type: Review

References (430)

1. Bangham, A. D.; Standish, M. M.; Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 1965, 13, 238-252
2. Sessa, G.; Weissmann, G. Incorporation of lysozyme into liposomes. A model for structure-linked latency J. Biol. Chem. 1970, 245, 3295-3301
3. Gregoriadis, G. The carrier potential of liposomes in biology and medicine (first of two parts) N. Engl. J. Med. 1976, 295, 704-710
4. Gregoriadis, G. The carrier potential of liposomes in biology and medicine (second of two parts) N. Engl. J. Med. 1976, 295, 765-770
5. Vanlerberghe, G. Liposomes in cosmetics: how and why. In Handbook of Nonmedical Applications of Liposomes, Vol. IV: From Gene Delivery and Diagnosis to Ecology; Lasic, D. B.; Yechezkel, Eds.; CRC Press: Boca Raton, FL, 1996; Vol. 4, pp 77-90.
6. Mu, L.; Sprando, R. L. Application of nanotechnology in cosmetics Pharm. Res. 2010, 27, 1746-1749
7. Betz, G.; Aeppli, A.; Menshutina, N.; Leuenberger, H. In vivo comparison of various liposome formulations for cosmetic application Int. J. Pharm. 2005, 296, 44-54
8. Mozafari, M. R.; Johnson, C.; Hatziantoniou, S.; Demetzos, C. Nanoliposomes and their applications in food nanotechnology J. Liposome Res. 2008, 18, 309-327
9. Taylor, T. M.; Davidson, P. M.; Bruce, B. D.; Weiss, J. Liposomal nanocapsules in food science and agriculture Crit. Rev. Food Sci. Nutr. 2005, 45, 587-605
10. Torchilin, V. P. Multifunctional nanocarriers Adv. Drug Delivery Rev. 2012, 64, 302-315
11. Israelachvili, J. N.; Marcelja, S.; Horn, R. G. Physical principles of membrane organization Q. Rev. Biophys. 1980, 13, 121-200
12. Lasic, D. D. Novel applications of liposomes Trends. Biotechnol. 1998, 16, 307-321
13. Du Plessis, J.; Ramachandran, C.; Weiner, N.; Müller, D. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage Int. J. Pharm. 1996, 127, 273-278
14. Frohlich, M.; Brecht, V.; Peschka-Suss, R. Parameters influencing the determination of liposome lamellarity by 31P-NMR Chem. Phys. Lipids 2001, 109, 103-112
15. Gardikis, K.; Tsimplouli, C.; Dimas, K.; Micha-Screttas, M.; Demetzos, C. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers Int. J. Pharm. 2010, 402, 231-237
16. Barenholz, Y. Doxil(R) - the first FDA-approved nano-drug: lessons learned J. Controlled Release 2012, 160, 117-134
17. Park, J. W. Liposome-based drug delivery in breast cancer treatment Breast Cancer Res. 2002, 4, 95-99
18. Andreopoulou, E.; Gaiotti, D.; Kim, E.; Downey, A.; Mirchandani, D.; Hamilton, A.; Jacobs, A.; Curtin, J.; Muggia, F. Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer Ann. Oncol. 2007, 18, 716-721
19. Chou, H. H.; Wang, K. L.; Chen, C. A.; Wei, L. H.; Lai, C. H.; Hsieh, C. Y.; Yang, Y. C.; Twu, N. F.; Chang, T. C.; Yen, M. S. Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up Gynecol. Oncol. 2006, 101, 423-428
20. Fassas, A.; Anagnostopoulos, A. The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia Leuk. Lymphoma. 2005, 46, 795-802
21. Silverman, J. A.; Deitcher, S. R. Marqibo(R) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine Cancer Chemother. Pharmacol. 2013, 71, 555-564
22. Meunier, F.; Prentice, H. G.; Ringden, O. Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial J. Antimicrob. Chemother. 1991, 28, 83-91
23. Wasan, K. M.; Lopez-Berestein, G. Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients Clin. Infect. Dis. 1996, 23, 1126-1138
24. Clemons, K. V.; Stevens, D. A. Comparative efficacies of four amphotericin B formulations - Fungizone, amphotec (Amphocil), AmBisome, and Abelcet - against systemic murine aspergillosis Antimicrob. Agents Chemother. 2004, 48, 1047-1050
25. Glantz, M. J.; Jaeckle, K. A.; Chamberlain, M. C.; Phuphanich, S.; Recht, L.; Swinnen, L. J.; Maria, B.; LaFollette, S.; Schumann, G. B.; Cole, B. F.; Howell, S. B. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors Clin. Cancer Res. 1999, 5, 3394-3402
26. Verteporfin Roundtable, P. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 2005, 25, 119-134
27. Photodynamic therapy with verteporfin (Visudyne) for macular degeneration. Med. Lett. Drugs Ther. 2000, 42, 81-82.
28. Bressler, N. M.; Bressler, S. B. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences Invest. Ophthalmol. Visual Sci. 2000, 41, 624-628
29. Gambling, D.; Hughes, T.; Martin, G.; Horton, W.; Manvelian, G. A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery Anesth. Analg. 2005, 100, 1065-1074
30. Carvalho, B.; Roland, L. M.; Chu, L. F.; Campitelli, V. A., III; Riley, E. T. Single-dose, extended-release epidural morphine (DepoDur) compared to conventional epidural morphine for post-cesarean pain Anesth. Analg. 2007, 105, 176-183
31. Usonis, V.; Bakasenas, V.; Valentelis, R.; Katiliene, G.; Vidzeniene, D.; Herzog, C. Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal) Vaccine 2003, 21, 4588-4592
32. Mischler, R.; Metcalfe, I. C.; Inflexal, V. A trivalent virosome subunit influenza vaccine: production Vaccine 2002, 20, B17-23
33. Zhang, J. A.; Anyarambhatla, G.; Ma, L.; Ugwu, S.; Xuan, T.; Sardone, T.; Ahmad, I. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation Eur. J. Pharm. Biopharm. 2005, 59, 177-187
34. Slingerland, M.; Guchelaar, H. J.; Rosing, H.; Scheulen, M. E.; van Warmerdam, L. J.; Beijnen, J. H.; Gelderblom, H. Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer Clin. Ther. 2013, 35, 1946-1954
35. Schuch, G. EndoTAG-1. MediGene Curr. Opin. Invest. Drugs 2005, 6, 1259-1265
36. Eichhorn, M. E.; Ischenko, I.; Luedemann, S.; Strieth, S.; Papyan, A.; Werner, A.; Bohnenkamp, H.; Guenzi, E.; Preissler, G.; Michaelis, U.; Jauch, K. W.; Bruns, C. J.; Dellian, M. Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer Int. J. Cancer 2010, 126, 1235-1245
37. Fasol, U.; Frost, A.; Buchert, M.; Arends, J.; Fiedler, U.; Scharr, D.; Scheuenpflug, J.; Mross, K. Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis Ann. Oncol. 2012, 23, 1030-1036
38. Yarmolenko, P. S.; Zhao, Y.; Landon, C.; Spasojevic, I.; Yuan, F.; Needham, D.; Viglianti, B. L.; Dewhirst, M. W. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours Int. J. Hyperthermia 2010, 26, 485-498
39. Mamot, C.; Ritschard, R.; Wicki, A.; Stehle, G.; Dieterle, T.; Bubendorf, L.; Hilker, C.; Deuster, S.; Herrmann, R.; Rochlitz, C. Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study Lancet Oncol. 2012, 13, 1234-1241
40. Saif, M. W. MM-398 achieves primary endpoint of overall survival in phase III study in patients with gemcitabine refractory metastatic pancreatic cancer JOP 2014, 15, 278-279
41. Roy, A. C.; Park, S. R.; Cunningham, D.; Kang, Y. K.; Chao, Y.; Chen, L. T.; Rees, C.; Lim, H. Y.; Tabernero, J.; Ramos, F. J.; Kujundzic, M.; Cardic, M. B.; Yeh, C. G.; de Gramont, A. A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma Ann. Oncol. 2013, 24, 1567-1573
42. Ko, A. H.; Tempero, M. A.; Shan, Y. S.; Su, W. C.; Lin, Y. L.; Dito, E.; Ong, A.; Wang, Y. W.; Yeh, C. G.; Chen, L. T. A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer Br. J. Cancer 2013, 109, 920-925
43. Tari, A. M.; Gutierrez-Puente, Y.; Monaco, G.; Stephens, C.; Sun, T.; Rosenblum, M.; Belmont, J.; Arlinghaus, R.; Lopez-Berestein, G. Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts Int. J. Oncol. 2007, 31, 1243-1250
44. Harrington, K. J.; Lewanski, C. R.; Northcote, A. D.; Whittaker, J.; Wellbank, H.; Vile, R. G.; Peters, A. M.; Stewart, J. S. Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer Ann. Oncol. 2001, 12, 493-496
45. Hoving, S.; van Tiel, S. T.; Eggermont, A. M.; ten Hagen, T. L. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats Anticancer Res. 2005, 25, 743-750
46. Farhat, F. S.; Temraz, S.; Kattan, J.; Ibrahim, K.; Bitar, N.; Haddad, N.; Jalloul, R.; Hatoum, H. A.; Nsouli, G.; Shamseddine, A. I. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer Clin. Breast Cancer 2011, 11, 384-389
47. Casagrande, N.; Celegato, M.; Borghese, C.; Mongiat, M.; Colombatti, A.; Aldinucci, D. Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer Clin. Cancer Res. 2014, 20, 5496-5506
48. Mylonakis, N.; Athanasiou, A.; Ziras, N.; Angel, J.; Rapti, A.; Lampaki, S.; Politis, N.; Karanikas, C.; Kosmas, C. Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer Lung Cancer 2010, 68, 240-247
49. Ravaioli, A.; Papi, M.; Pasquini, E.; Marangolo, M.; Rudnas, B.; Fantini, M.; Nicoletti, S. V.; Drudi, F.; Panzini, I.; Tamburini, E.; Gianni, L.; Pasini, G. Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancer J. Chemother. 2009, 21, 86-90
50. Stathopoulos, G. P.; Boulikas, T. Lipoplatin formulation review article J. Drug Delivery 2012, 2012, 581363
51. Cattaneo, A. G.; Gornati, R.; Sabbioni, E.; Chiriva-Internati, M.; Cobos, E.; Jenkins, M. R.; Bernardini, G. Nanotechnology and human health: risks and benefits J. Appl. Toxicol. 2010, 30, 730-744
52. Wu, Y. L.; Park, K.; Soo, R. A.; Sun, Y.; Tyroller, K.; Wages, D.; Ely, G.; Yang, J. C.; Mok, T. INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer BMC Cancer 2011, 11, 430
53. Booser, D. J.; Esteva, F. J.; Rivera, E.; Valero, V.; Esparza-Guerra, L.; Priebe, W.; Hortobagyi, G. N. Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer Cancer Chemother. Pharmacol. 2002, 50, 6-8
54. Wetzler, M.; Thomas, D. A.; Wang, E. S.; Shepard, R.; Ford, L. A.; Heffner, T. L.; Parekh, S.; Andreeff, M.; O'Brien, S.; Kantarjian, H. M. Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia Clin. Lymphoma, Myeloma. Leuk. 2013, 13, 430-434
55. Tardi, P.; Choice, E.; Masin, D.; Redelmeier, T.; Bally, M.; Madden, T. D. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models Cancer Res. 2000, 60, 3389-3393
56. Semple, S. C.; Leone, R.; Wang, J.; Leng, E. C.; Klimuk, S. K.; Eisenhardt, M. L.; Yuan, Z. N.; Edwards, K.; Maurer, N.; Hope, M. J.; Cullis, P. R.; Ahkong, Q. F. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity J. Pharm. Sci. 2005, 94, 1024-1038
57. Clancy, J. P.; Dupont, L.; Konstan, M. W.; Billings, J.; Fustik, S.; Goss, C. H.; Lymp, J.; Minic, P.; Quittner, A. L.; Rubenstein, R. C.; Young, K. R.; Saiman, L.; Burns, J. L.; Govan, J. R.; Ramsey, B.; Gupta, R. Arikace Study, G. Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection Thorax 2013, 68, 818-825
58. Gaillard, P. J.; Kerklaan, B. M.; Aftimos, P.; Altintas, S.; Jager, A.; Gladdines, W.; Lonnqvist, F.; Soetekouw, P.; Verheul, H.; Awada, A. Abstract CT216: Phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma Cancer Res. 2014, 74, CT216-CT216
59. Serisier, D. J.; Bilton, D.; De Soyza, A.; Thompson, P. J.; Kolbe, J.; Greville, H. W.; Cipolla, D.; Bruinenberg, P.; Gonda, I. investigators, O.-. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial Thorax 2013, 68, 812-817
60. Samad, A.; Sultana, Y.; Aqil, M. Liposomal drug delivery systems: an update review Curr. Drug Delivery 2007, 4, 297-305
61. Sriraman, S. K.; Torchilin, V. P. Recent Advances with Liposomes as Drug Carriers. Advanced Biomaterials and Biodevices; John Wiley & Sons, Inc.: Hoboken, NJ, 2014; pp 79-119.
62. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
63. Liu, Y.; Lu, W. L.; Zhang, Q. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery] Zhongguo Yixue Kexueyuan Xuebao 2006, 28, 583-589
64. Ebrahim, S.; Peyman, G. A.; Lee, P. J. Applications of liposomes in ophthalmology Surv. Ophthalmol. 2005, 50, 167-182
65. Lian, T.; Ho, R. J. Trends and developments in liposome drug delivery systems J. Pharm. Sci. 2001, 90, 667-680
66. Vemuri, S.; Rhodes, C. T. Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharm. Acta Helv. 1995, 70, 95-111
67. Taylor, K.; Taylor, G.; Kellaway, I.; Stevens, J. Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes Int. J. Pharm. 1990, 58, 49-55
68. de Kruyff, B.; Demel, R. A.; van Deenen, L. L. The effect of cholesterol and epicholesterol incorporation on the permeability and on the phase transition of intact Acholeplasma laidlawii cell membranes and derived liposomes Biochim. Biophys. Acta 1972, 255, 331-347
69. Kirby, C.; Clarke, J.; Gregoriadis, G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro Biochem. J. 1980, 186, 591-598
70. Lopez-Pinto, J. M.; Gonzalez-Rodriguez, M. L.; Rabasco, A. M. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes Int. J. Pharm. 2005, 298, 1-12
71. Juliano, R. L.; Stamp, D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs Biochem. Biophys. Res. Commun. 1975, 63, 651-658
72. Johnson, S. M. The effect of charge and cholesterol on the size and thickness of sonicated phospholipid vesicles Biochim. Biophys. Acta 1973, 307, 27-41
73. Miller, C. R.; Bondurant, B.; McLean, S. D.; McGovern, K. A.; OBrien, D. F. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes Biochemistry 1998, 37, 12875-12883
74. Campbell, R. B.; Fukumura, D.; Brown, E. B.; Mazzola, L. M.; Izumi, Y.; Jain, R. K.; Torchilin, V. P.; Munn, L. L. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors Cancer Res. 2002, 62, 6831-6836
75. Cipolla, D.; Wu, H.; Gonda, I.; Eastman, S.; Redelmeier, T.; Chan, H. K. Modifying the release properties of liposomes toward personalized medicine J. Pharm. Sci. 2014, 103, 1851-1862
76. Bangham, A.; De Gier, J.; Greville, G. Osmotic properties and water permeability of phospholipid liquid crystals Chem. Phys. Lipids 1967, 1, 225-246
77. Reeves, J. P.; Dowben, R. M. Formation and properties of thin-walled phospholipid vesicles J. Cell. Physiol. 1969, 73, 49-60
78. Saunders, L.; Perrin, J.; Gammack, D. Ultrasonic irradiation of some phospholipid sols J. Pharm. Pharmacol. 1962, 14, 567-572
79. Hargreaves, W. R.; Deamer, D. W. Liposomes from ionic, single-chain amphiphiles Biochemistry 1978, 17, 3759-3768
80. Parente, R. A.; Lentz, B. R. Phase behavior of large unilamellar vesicles composed of synthetic phospholipids Biochemistry 1984, 23, 2353-2362
81. Biswas, S.; Dodwadkar, N. S.; Deshpande, P. P.; Torchilin, V. P. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo J. Controlled Release 2012, 159, 393-402
82. Hope, M. J.; Bally, M. B.; Webb, G.; Cullis, P. R. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential Biochim. Biophys. Acta 1985, 812, 55-65
83. Popa, R.; Vranceanu, M.; Nikolaus, S.; Nirschl, H.; Leneweit, G. Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannels Langmuir 2008, 24, 13030-13036
84. Szoka, F., Jr.; Papahadjopoulos, D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 4194-4198
85. Stano, P.; Bufali, S.; Pisano, C.; Bucci, F.; Barbarino, M.; Santaniello, M.; Carminati, P.; Luisi, P. L. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method J. Liposome Res. 2004, 14, 87-109
86. Deamer, D. W. Preparation and properties of ether-injection liposomes Ann. N. Y. Acad. Sci. 1978, 308, 250-258
87. Schieren, H.; Rudolph, S.; Finkelstein, M.; Coleman, P.; Weissmann, G. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses Biochim. Biophys. Acta 1978, 542, 137-153
88. Batzri, S.; Korn, E. D. Single bilayer liposomes prepared without sonication Biochim. Biophys. Acta 1973, 298, 1015-1019
89. Alpes, H.; Allmann, K.; Plattner, H.; Reichert, J.; Rick, R.; Schulz, S. Formation of large unilamellar vesicles using alkyl maltoside detergents Biochim. Biophys. Acta 1986, 862, 294-302
90. Enoch, H. G.; Strittmatter, P. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 145-149
91. Philippot, J. R.; Mutaftschiev, S.; Liautard, J. P. Extemporaneous preparation of large unilamellar liposomes Biochim. Biophys. Acta 1985, 821, 79-84
92. Jahn, A.; Vreeland, W. N.; Gaitan, M.; Locascio, L. E. Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing J. Am. Chem. Soc. 2004, 126, 2674-2675
93. van Swaay, D.; deMello, A. Microfluidic methods for forming liposomes Lab. Chip. 2013, 13, 752-767
94. Jahn, A.; Stavis, S. M.; Hong, J. S.; Vreeland, W. N.; DeVoe, D. L.; Gaitan, M. Microfluidic mixing and the formation of nanoscale lipid vesicles ACS Nano 2010, 4, 2077-2087
95. Hood, R. R.; Shao, C.; Omiatek, D. M.; Vreeland, W. N.; DeVoe, D. L. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers Pharm. Res. 2013, 30, 1597-1607
96. Balbino, T. A.; Aoki, N. T.; Gasperini, A. A.; Oliveira, C. L.; Azzoni, A. R.; Cavalcanti, L. P.; de la Torre, L. G. Continuous flow production of cationic liposomes at high lipid concentration in microfluidic devices for gene delivery applications Chem. Eng. J. 2013, 226, 423-433
97. Vladisavljević, G. T.; Laouini, A.; Charcosset, C.; Fessi, H.; Bandulasena, H. C.; Holdich, R. G. Production of liposomes using microengineered membrane and co-flow microfluidic device. Colloids Surf., A 2014.
98. Kastner, E.; Kaur, R.; Lowry, D.; Moghaddam, B.; Wilkinson, A.; Perrie, Y. High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization Int. J. Pharm. 2014, 477, 361-368
99. Otake, K.; Imura, T.; Sakai, H.; Abe, M. Development of a new preparation method of liposomes using supercritical carbon dioxide Langmuir 2001, 17, 3898-3901
100. Santo, I. E.; Pedro, A. S.; Fialho, R.; Cabral-Albuquerque, E. Characteristics of lipid micro- and nanoparticles based on supercritical formation for potential pharmaceutical application Nanoscale Res. Lett. 2013, 8, 386
101. Otake, K.; Shimomura, T.; Goto, T.; Imura, T.; Furuya, T.; Yoda, S.; Takebayashi, Y.; Sakai, H.; Abe, M. Preparation of liposomes using an improved supercritical reverse phase evaporation method Langmuir 2006, 22, 2543-2550
102. Santo, I. E.; Campardelli, R.; Albuquerque, E. C.; de Melo, S. V.; Della Porta, G.; Reverchon, E. Liposomes preparation using a supercritical fluid assisted continuous process Chem. Eng. J. 2014, 249, 153-159
103. Magnan, C.; Badens, E.; Commenges, N.; Charbit, G. Soy lecithin micronization by precipitation with a compressed fluid antisolvent-influence of process parameters J. Supercrit. Fluids 2000, 19, 69-77
104. Lesoin, L.; Crampon, C.; Boutin, O.; Badens, E. Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method J. Supercrit. Fluids 2011, 57, 162-174
105. Karn, P. R.; Cho, W.; Park, H. J.; Park, J. S.; Hwang, S. J. Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method Int. J. Nanomed. 2013, 8, 365-377
106. Li, C.; Deng, Y. A novel method for the preparation of liposomes: freeze drying of monophase solutions J. Pharm. Sci. 2004, 93, 1403-1414
107. Wang, T.; Deng, Y.; Geng, Y.; Gao, Z.; Zou, J.; Wang, Z. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions Biochim. Biophys. Acta 2006, 1758, 222-231
108. Cui, J.; Li, C.; Deng, Y.; Wang, Y.; Wang, W. Freeze-drying of liposomes using tertiary butyl alcohol/water cosolvent systems Int. J. Pharm. 2006, 312, 131-136
109. Pereira, C. S.; Lins, R. D.; Chandrasekhar, I.; Freitas, L. C.; Hunenberger, P. H. Interaction of the disaccharide trehalose with a phospholipid bilayer: a molecular dynamics study Biophys. J. 2004, 86, 2273-2285
110. Sum, A. K.; Faller, R.; de Pablo, J. J. Molecular simulation study of phospholipid bilayers and insights of the interactions with disaccharides Biophys. J. 2003, 85, 2830-2844
111. Crowe, J. H.; Crowe, L. M. Factors affecting the stability of dry liposomes Biochim. Biophys. Acta 1988, 939, 327-334
112. Chen, C.; Han, D.; Cai, C.; Tang, X. An overview of liposome lyophilization and its future potential J. Controlled Release 2010, 142, 299-311
113. Sollohub, K.; Cal, K. Spray drying technique: II. Current applications in pharmaceutical technology J. Pharm. Sci. 2010, 99, 587-597
114. Skalko-Basnet, N.; Pavelic, Z.; Becirevic-Lacan, M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method Drug. Dev. Ind. Pharm. 2000, 26, 1279-1284
115. Patil-Gadhe, A.; Pokharkar, V. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach Pulm. Pharmacol. Ther. 2014, 27, 197-207
116. Rojanarat, W.; Changsan, N.; Tawithong, E.; Pinsuwan, S.; Chan, H. K.; Srichana, T. Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies Int. J. Mol. Sci. 2011, 12, 4414-4434
117. Jaafar-Maalej, C.; Charcosset, C.; Fessi, H. A new method for liposome preparation using a membrane contactor J. Liposome Res. 2011, 21, 213-220
118. Laouini, A.; Jaafar-Maalej, C.; Sfar, S.; Charcosset, C.; Fessi, H. Liposome preparation using a hollow fiber membrane contactor - application to spironolactone encapsulation Int. J. Pharm. 2011, 415, 53-61
119. Pham, T. T.; Jaafar-Maalej, C.; Charcosset, C.; Fessi, H. Liposome and niosome preparation using a membrane contactor for scale-up Colloids Surf., B 2012, 94, 15-21
120. Peschka, R.; Purmann, T.; Schubert, R. Cross-flow filtration-an improved detergent removal technique for the preparation of liposomes Int. J. Pharm. 1998, 162, 177-183
121. Wagner, A.; Vorauer-Uhl, K.; Kreismayr, G.; Katinger, H. The crossflow injection technique: an improvement of the ethanol injection method J. Liposome Res. 2002, 12, 259-270
122. Wagner, A.; Vorauer-Uhl, K.; Kreismayr, G.; Katinger, H. Enhanced protein loading into liposomes by the multiple crossflow injection technique J. Liposome Res. 2002, 12, 271-283
123. Wagner, A.; Platzgummer, M.; Kreismayr, G.; Quendler, H.; Stiegler, G.; Ferko, B.; Vecera, G.; Vorauer-Uhl, K.; Katinger, H. GMP production of liposomes - a new industrial approach J. Liposome Res. 2006, 16, 311-319
124. Manojlovic, V.; Winkler, K.; Bunjes, V.; Neub, A.; Schubert, R.; Bugarski, B.; Leneweit, G. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein Colloids Surf., B 2008, 64, 284-296
125. Zadi, B.; Gregoriadis, G. A novel method for high-yield entrapment of solutes into small liposomes J. Liposome Res. 2000, 10, 73-80
126. Hwang, S. H.; Maitani, Y.; Qi, X. R.; Takayama, K.; Nagai, T. Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods Int. J. Pharm. 1999, 179, 85-95
127. Dos Santos, N.; Cox, K. A.; McKenzie, C. A.; van Baarda, F.; Gallagher, R. C.; Karlsson, G.; Edwards, K.; Mayer, L. D.; Allen, C.; Bally, M. B. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol Biochim. Biophys. Acta 2004, 1661, 47-60
128. Abraham, S. A.; Edwards, K.; Karlsson, G.; Hudon, N.; Mayer, L. D.; Bally, M. B. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes J. Controlled Release 2004, 96, 449-461
129. Han, H. D.; Lee, A.; Song, C. K.; Hwang, T.; Seong, H.; Lee, C. O.; Shin, B. C. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes Int. J. Pharm. 2006, 313, 181-188
130. Sioud, M.; Sorensen, D. R. Cationic liposome-mediated delivery of siRNAs in adult mice Biochem. Biophys. Res. Commun. 2003, 312, 1220-1225
131. Safinya, C. R. Structures of lipid-DNA complexes: supramolecular assembly and gene delivery Curr. Opin. Struct. Biol. 2001, 11, 440-448
132. Matsuura, M.; Yamazaki, Y.; Sugiyama, M.; Kondo, M.; Ori, H.; Nango, M.; Oku, N. Polycation liposome-mediated gene transfer in vivo Biochim. Biophys. Acta 2003, 1612, 136-143
133. Ruozi, B.; Battini, R.; Montanari, M.; Mucci, A.; Tosi, G.; Forni, F.; Vandelli, M. A. DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery Nanomedicine 2007, 3, 1-13
134. Toh, M.-R.; Chiu, G. N. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing Asian J. Pharm. Sci. 2013, 8, 88-95
135. Kellogg, E. W., III; Fridovich, I. Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide J. Biol. Chem. 1977, 252, 6721-6728
136. Erdogan, S.; Özer, A. Y.; Ekizoglu, M.; Özalp, M.; COlak, Ş.; Korkmaz, M. Gamma irradiation of liposomal phospholipids FABAD J. Pharm. Sci. 2006, 31, 182-190
137. Zuidam, N. J.; Versluis, C.; Vernooy, E. A.; Crommelin, D. J. Gamma-irradiation of liposomes composed of saturated phospholipids: effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes Biochim. Biophys. Acta 1996, 1280, 135-148
138. Crowe, J. H.; McKersie, B. D.; Crowe, L. M. Effects of free fatty acids and transition temperature on the stability of dry liposomes Biochim. Biophys. Acta 1989, 979, 7-10
139. Torchilin, V. P.; Omelyanenko, V. G.; Lukyanov, A. N. Temperature-dependent aggregation of pH-sensitive phosphatidyl ethanolamine-oleic acid-cholesterol liposomes as measured by fluorescent spectroscopy Anal. Biochem. 1992, 207, 109-113
140. Brandl, M. Vesicular phospholipid gels Methods Mol. Biol. 2010, 605, 205-212
141. Zuidam, N. J.; Lee, S. S.; Crommelin, D. J. Sterilization of liposomes by heat treatment Pharm. Res. 1993, 10, 1591-1596
142. Ratz, H.; Freise, J.; Magerstedt, P.; Schaper, A.; Preugschat, W.; Keyser, D. Sterilization of contrast media (Isovist) containing liposomes by ethylene oxide J. Microencapsulation 1989, 6, 485-492
143. Mohammed, A. R.; Bramwell, V. W.; Coombes, A. G.; Perrie, Y. Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products Methods 2006, 40, 30-38
144. Zuidam, N. J.; Lee, S. S.; Crommelin, D. J. Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes Pharm. Res. 1995, 12, 1761-1768
145. Andras, C. D.; Csajagi, C.; Orban, C. K.; Albert, C.; Abraham, B.; Miklossy, I. A possible explanation of the germicide effect of carbon dioxide in supercritical state based on molecular-biological evidence Med. Hypotheses 2010, 74, 325-329
146. Fages, J.; Poirier, B.; Barbier, Y.; Frayssinet, P.; Joffret, M. L.; Majewski, W.; Bonel, G.; Larzul, D. Viral inactivation of human bone tissue using supercritical fluid extraction ASAIO J. 1998, 44, 289-293
147. White, A.; Burns, D.; Christensen, T. W. Effective terminal sterilization using supercritical carbon dioxide J. Biotechnol. 2006, 123, 504-515
148. Liu, H.; Finn, N.; Yates, M. Z. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation Langmuir 2005, 21, 379-385
149. Dillow, A. K.; Dehghani, F.; Hrkach, J. S.; Foster, N. R.; Langer, R. Bacterial inactivation by using near- and supercritical carbon dioxide Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 10344-10348
150. Crommelin, D. J.; Storm, G. Liposomes: from the bench to the bed J. Liposome Res. 2003, 13, 33-36
151. Berger, N.; Sachse, A.; Bender, J.; Schubert, R.; Brandl, M. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics Int. J. Pharm. 2001, 223, 55-68
152. Provder, T. Challenges in particle size distribution measurement past, present and for the 21st century Prog. Org. Coat. 1997, 32, 143-153
153. Lundahl, P.; Zeng, C. M.; Lagerquist Hagglund, C.; Gottschalk, I.; Greijer, E. Chromatographic approaches to liposomes, proteoliposomes and biomembrane vesicles J. Chromatogr. B: Biomed. Sci. Appl. 1999, 722, 103-120
154. Lesieur, S.; Grabielle-Madelmont, C.; Paternostre, M. T.; Ollivon, M. Size analysis and stability study of lipid vesicles by high-performance gel exclusion chromatography, turbidity, and dynamic light scattering Anal. Biochem. 1991, 192, 334-343
155. Elhissi, A. M.; Faizi, M.; Naji, W. F.; Gill, H. S.; Taylor, K. M. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures Int. J. Pharm. 2007, 334, 62-70
156. Chattopadhyay, S.; Ehrman, S. H.; Venkataraman, C. Size distribution and dye release properties of submicron liposome aerosols Powder Technol. 2013, 246, 530-538
157. Gustafsson, J.; Arvidson, G.; Karlsson, G.; Almgren, M. Complexes between cationic liposomes and DNA visualized by cryo-TEM Biochim. Biophys. Acta 1995, 1235, 305-312
158. Kuntsche, J.; Horst, J. C.; Bunjes, H. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems Int. J. Pharm. 2011, 417, 120-137
159. Ruozi, B.; Tosi, G.; Forni, F.; Fresta, M.; Vandelli, M. A. Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes Eur. J. Pharm. Sci. 2005, 25, 81-89
160. Filipe, V.; Hawe, A.; Jiskoot, W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates Pharm. Res. 2010, 27, 796-810
161. Reshetov, V.; Zorin, V.; Siupa, A.; DHallewin, M. A.; Guillemin, F.; Bezdetnaya, L. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction Photochem. Photobiol. 2012, 88, 1256-1264
162. Ohlsson, G.; Tabaei, S. R.; Beech, J.; Kvassman, J.; Johanson, U.; Kjellbom, P.; Tegenfeldt, J. O.; Hook, F. Solute transport on the sub 100 ms scale across the lipid bilayer membrane of individual proteoliposomes Lab Chip 2012, 12, 4635-4643
163. Hansen, M. B.; van Emmerik, C.; van Gaal, E.; Storm, G.; van Hest, J. C.; Löwik, D. W. Quick-and-easy preparation and purification of quantum dot-loaded liposomes J. Nanopart. Res. 2013, 15, 1-9
164. Hunter, R. J.; Midmore, B. R.; Zhang, H. Zeta Potential of Highly Charged Thin Double-Layer Systems J. Colloid Interface Sci. 2001, 237, 147-149
165. Schlieper, P.; Medda, P. K.; Kaufmann, R. Drug-induced zeta potential changes in liposomes studied by laser Doppler spectroscopy Biochim. Biophys. Acta 1981, 644, 273-283
166. Takeuchi, K.; Ishihara, M.; Kawaura, C.; Noji, M.; Furuno, T.; Nakanishi, M. Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection FEBS Lett. 1996, 397, 207-209
167. Edwards, K. A.; Baeumner, A. J. Analysis of liposomes Talanta 2006, 68, 1432-1441
168. Mukherjee, S.; Raghuraman, H.; Dasgupta, S.; Chattopadhyay, A. Organization and dynamics of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids: a fluorescence approach Chem. Phys. Lipids 2004, 127, 91-101
169. Chattopadhyay, A. Chemistry and biology of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids: fluorescent probes of biological and model membranes Chem. Phys. Lipids 1990, 53, 1-15
170. Hauser, H. Some aspects of the phase behaviour of charged lipids Biochim. Biophys. Acta 1984, 772, 37-50
171. Laouini, A.; Jaafar-Maalej, C.; Limayem-Blouza, I.; Sfar, S.; Charcosset, C.; Fessi, H. Preparation, characterization and applications of liposomes: state of the art J. Colloid Sci. Biotechnol. 2012, 1, 147-168
172. Stampoulis, P.; Ueda, T.; Matsumoto, M.; Terasawa, H.; Miyano, K.; Sumimoto, H.; Shimada, I. Atypical membrane-embedded phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2)-binding site on p47(phox) Phox homology (PX) domain revealed by NMR J. Biol. Chem. 2012, 287, 17848-17859
173. Bouwstra, J. A.; Gooris, G. S.; Bras, W.; Talsma, H. Small angle X-ray scattering: possibilities and limitations in characterization of vesicles Chem. Phys. Lipids 1993, 64, 83-98
174. Muller, M.; Mackeben, S.; Muller-Goymann, C. C. Physicochemical characterisation of liposomes with encapsulated local anaesthetics Int. J. Pharm. 2004, 274, 139-148
175. Müller, M.; Mackeben, S.; Müller-Goymann, C. C. Physicochemical characterisation of liposomes with encapsulated local anaesthetics Int. J. Pharm. 2004, 274, 139-148
176. Mayer, L. D.; Hope, M. J.; Cullis, P. R.; Janoff, A. S. Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles Biochim. Biophys. Acta 1985, 817, 193-196
177. Tunsirikongkon, A.; Charernruttanakul, A.; Sarisuta, N. Physical properties of proliposome for industrial quality control and reconstitution of proliposome in porcine intestinal mucosa Int. J. Pharm. Pharm. Sci. 2014, 6, 546-551
178. Sun, C.; Wang, J.; Liu, J.; Qiu, L.; Zhang, W.; Zhang, L. Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics AAPS PharmSciTech 2013, 14, 332-338
179. Bandari, S.; Gangishetty, S.; Eedara, B. B.; Jukanti, R.; Veerareddy, P. R. Proliposomes of lisinopril dihydrate for transdermal delivery: Formulation aspects and evaluation Korean J. Chem. Eng. 2013, 30, 1659-1666
180. Manconi, M.; Caddeo, C.; Sinico, C.; Valenti, D.; Mostallino, M. C.; Biggio, G.; Fadda, A. M. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction Eur. J. Pharm. Biopharm. 2011, 78, 27-35
181. Gillet, A.; Lecomte, F.; Hubert, P.; Ducat, E.; Evrard, B.; Piel, G. Skin penetration behaviour of liposomes as a function of their composition Eur. J. Pharm. Biopharm. 2011, 79, 43-53
182. Elsayed, M. M.; Abdallah, O. Y.; Naggar, V. F.; Khalafallah, N. M. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery Int. J. Pharm. 2006, 322, 60-66
183. Kelly, C.; Jefferies, C.; Cryan, S. A. Targeted liposomal drug delivery to monocytes and macrophages J. Drug Delivery 2011, 2011, 727241
184. Allen, T. M.; Everest, J. M. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats J. Pharmacol. Exp. Ther. 1983, 226, 539-544
185. Nagayasu, A.; Uchiyama, K.; Kiwada, H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs Adv. Drug Delivery Rev. 1999, 40, 75-87
186. Allen, T. M.; Hansen, C.; Rutledge, J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues Biochim. Biophys. Acta 1989, 981, 27-35
187. Gill, P. S.; Wernz, J.; Scadden, D. T.; Cohen, P.; Mukwaya, G. M.; von Roenn, J. H.; Jacobs, M.; Kempin, S.; Silverberg, I.; Gonzales, G.; Rarick, M. U.; Myers, A. M.; Shepherd, F.; Sawka, C.; Pike, M. C.; Ross, M. E. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma J. Clin. Oncol. 1996, 14, 2353-2364
188. Gabizon, A.; Papahadjopoulos, D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6949-6953
189. Maruyama, K.; Yuda, T.; Okamoto, A.; Kojima, S.; Suginaka, A.; Iwatsuru, M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol) Biochim. Biophys. Acta 1992, 1128, 44-49
190. Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 1990, 268, 235-237
191. Papisov, M. I. Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions Adv. Drug Delivery Rev. 1998, 32, 119-138
192. Senior, J.; Delgado, C.; Fisher, D.; Tilcock, C.; Gregoriadis, G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles Biochim. Biophys. Acta 1991, 1062, 77-82
193. Woodle, M. C. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation Chem. Phys. Lipids 1993, 64, 249-262
194. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 1995, 55, 3752-3756
195. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4607-4612
196. Torchilin, V. Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Delivery Rev. 2011, 63, 131-135
197. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-6392
198. Fang, J.; Nakamura, H.; Maeda, H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Delivery Rev. 2011, 63, 136-151
199. Crielaard, B. J.; Lammers, T.; Schiffelers, R. M.; Storm, G. Drug targeting systems for inflammatory disease: one for all, all for one J. Controlled Release 2012, 161, 225-234
200. Hong, R. L.; Huang, C. J.; Tseng, Y. L.; Pang, V. F.; Chen, S. T.; Liu, J. J.; Chang, F. H. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 1999, 5, 3645-3652
201. Yokoi, K.; Tanei, T.; Godin, B.; van de Ven, A.; Alexander, J.; Ferrari, M. Tumor type and organ type dependent differences of vascular permeability to pegylated liposomal doxorubicin Cancer Res. 2013, 73, 4973-4973
202. Patel, N. R.; Pattni, B. S.; Abouzeid, A. H.; Torchilin, V. P. Nanopreparations to overcome multidrug resistance in cancer Adv. Drug Delivery Rev. 2013, 65, 1748-1762
203. Ferrari, M. Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005, 5, 161-171
204. Bae, Y. H. Drug targeting and tumor heterogeneity J. Controlled Release 2009, 133, 2-3
205. Torchilin, V. P. Liposomes as targetable drug carriers Crit. Rev. Ther. Drug Carrier Syst. 1985, 2, 65-115
206. van Rooy, I.; Hennink, W. E.; Storm, G.; Schiffelers, R. M.; Mastrobattista, E. Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding Eur. J. Pharm. Sci. 2012, 45, 330-335
207. Kirpotin, D.; Park, J. W.; Hong, K.; Zalipsky, S.; Li, W. L.; Carter, P.; Benz, C. C.; Papahadjopoulos, D. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro Biochemistry 1997, 36, 66-75
208. Blume, G.; Cevc, G.; Crommelin, M. D.; Bakker-Woudenberg, I. A.; Kluft, C.; Storm, G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times Biochim. Biophys. Acta 1993, 1149, 180-184
209. Maruyama, K.; Takizawa, T.; Yuda, T.; Kennel, S. J.; Huang, L.; Iwatsuru, M. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies Biochim. Biophys. Acta 1995, 1234, 74-80
210. Sawant, R. R.; Torchilin, V. P. Challenges in development of targeted liposomal therapeutics AAPS J. 2012, 14, 303-315
211. Park, J. W.; Hong, K.; Kirpotin, D. B.; Colbern, G.; Shalaby, R.; Baselga, J.; Shao, Y.; Nielsen, U. B.; Marks, J. D.; Moore, D.; Papahadjopoulos, D.; Benz, C. C. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 2002, 8, 1172-1181
212. Goren, D.; Horowitz, A. T.; Zalipsky, S.; Woodle, M. C.; Yarden, Y.; Gabizon, A. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies Br. J. Cancer 1996, 74, 1749-1756
213. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 2006, 66, 6732-6740
214. Sofou, S.; Sgouros, G. Antibody-targeted liposomes in cancer therapy and imaging Expert Opin. Drug Delivery 2008, 5, 189-204
215. Maruyama, K. PEG-immunoliposome Biosci. Rep. 2002, 22, 251-266
216. Munster, P.; Krop, I.; Miller, K.; Dhindsa, N.; Niyijiza, C.; Nielsen, U.; Odueyungbo, A.; Rajarethinam, A.; Marande, M.; Campbell, K. Abstract P4-12-29: Assessment of safety and activity in an expanded phase 1 study of MM-302, a HER2-targeted liposomal doxorubicin, in patients with advanced HER2-positive (HER2+) breast cancer Cancer Res. 2013, 73, P4-12-29-P14-12-29
217. Wickham, T.; Futch, K. A phase I study of MM-302, a HER2-targeted liposomal doxorubicin. Patients with advanced, HER2-positive breast cancer Cancer Res. 2012, 72, P5-P18
218. Wickham, T.; Reynolds, J.; Drummond, D.; Kirpotin, D.; Lahdenranta, J.; Leonard, S.; Geretti, E.; Lee, H.; Klinz, S.; Hendriks, B. Abstract P3-14-09: Preclinical Safety and Activity of MM-302, a HER2-Targeted Liposomal Doxorubicin Designed To Have an Improved Safety and Efficacy Profile over Approved Anthracyclines Cancer Res. 2010, 70, P3-14-09-P13-14-09
219. Lukyanov, A. N.; Elbayoumi, T. A.; Chakilam, A. R.; Torchilin, V. P. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody J. Controlled Release 2004, 100, 135-144
220. ElBayoumi, T. A.; Torchilin, V. P. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody Clin. Cancer Res. 2009, 15, 1973-1980
221. Matsumura, Y.; Gotoh, M.; Muro, K.; Yamada, Y.; Shirao, K.; Shimada, Y.; Okuwa, M.; Matsumoto, S.; Miyata, Y.; Ohkura, H.; Chin, K.; Baba, S.; Yamao, T.; Kannami, A.; Takamatsu, Y.; Ito, K.; Takahashi, K. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer Ann. Oncol. 2004, 15, 517-525
222. Sankhala, K.; Mita, A.; Adinin, R.; Wood, L.; Beeram, M.; Bullock, S.; Yamagata, N.; Matsuno, K.; Fujisawa, T.; Phan, A. A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin J. Clin. Oncol. 2009, 27, 2535
223. Senzer, N. N.; Matsuno, K.; Yamagata, N.; Fujisawa, T.; Wasserman, E.; Sutherland, W.; Sharma, S.; Phan, A. Abstract C36: MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/II study in gastro-esophageal adenocarcinoma, with pharmacokinetics Mol. Cancer Ther. 2009, 8, C36-C36
224. Yamada, A.; Taniguchi, Y.; Kawano, K.; Honda, T.; Hattori, Y.; Maitani, Y. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice Clin. Cancer Res. 2008, 14, 8161-8168
225. Gabizon, A.; Tzemach, D.; Gorin, J.; Mak, L.; Amitay, Y.; Shmeeda, H.; Zalipsky, S. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Cancer Chemother. Pharmacol. 2010, 66, 43-52
226. Riviere, K.; Huang, Z.; Jerger, K.; Macaraeg, N.; Szoka, F. C., Jr. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration J. Drug Targeting 2011, 19, 14-24
227. Low, P. S.; Poh, S. Delivery of agents to inflamed tissues using folate-targeted liposomes. U.S. Patent US20130071321 A1, May 27, 2011.
228. Bechara, C.; Sagan, S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013, 587, 1693-1702
229. Torchilin, V. P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 2008, 90, 604-610
230. Copolovici, D. M.; Langel, K.; Eriste, E.; Langel, U. Cell-penetrating peptides: design, synthesis, and applications ACS Nano 2014, 8, 1972-1994
231. Kloss, A.; Henklein, P.; Siele, D.; Schmolke, M.; Apcher, S.; Kuehn, L.; Sheppard, P. W.; Dahlmann, B. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities Eur. J. Pharm. Biopharm. 2009, 72, 219-225
232. Gupta, B.; Levchenko, T. S.; Torchilin, V. P. TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice Oncol. Res. 2007, 16, 351-359
233. Pappalardo, J. S.; Quattrocchi, V.; Langellotti, C.; Di Giacomo, S.; Gnazzo, V.; Olivera, V.; Calamante, G.; Zamorano, P. I.; Levchenko, T. S.; Torchilin, V. P. Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes J. Controlled Release 2009, 134, 41-46
234. Torchilin, V. P.; Levchenko, T. S.; Rammohan, R.; Volodina, N.; Papahadjopoulos-Sternberg, B.; D'Souza, G. G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1972-1977
235. Biswas, S.; Dodwadkar, N. S.; Deshpande, P. P.; Parab, S.; Torchilin, V. P. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity Eur. J. Pharm. Biopharm. 2013, 84, 517-525
236. Biswas, S.; Deshpande, P. P.; Perche, F.; Dodwadkar, N. S.; Sane, S. D.; Torchilin, V. P. Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer Cancer Lett. 2013, 335, 191-200
237. Yatvin, M. B.; Kreutz, W.; Horwitz, B. A.; Shinitzky, M. pH-sensitive liposomes: possible clinical implications Science 1980, 210, 1253-1255
238. Li, W.; Nicol, F.; Szoka, F. C., Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery Adv. Drug Delivery Rev. 2004, 56, 967-985
239. Andreev, O. A.; Engelman, D. M.; Reshetnyak, Y. K. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP) Chim. Oggi 2009, 27, 34-37
240. Yao, L.; Daniels, J.; Wijesinghe, D.; Andreev, O. A.; Reshetnyak, Y. K. pHLIP(R)-mediated delivery of PEGylated liposomes to cancer cells J. Controlled Release 2013, 167, 228-237
241. Sosunov, E. A.; Anyukhovsky, E. P.; Sosunov, A. A.; Moshnikova, A.; Wijesinghe, D.; Engelman, D. M.; Reshetnyak, Y. K.; Andreev, O. A. pH (low) insertion peptide (pHLIP) targets ischemic myocardium Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 82-86
242. Torchilin, V. P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery Nat. Rev. Drug Discovery 2014, 13, 813-827
243. Kale, A. A.; Torchilin, V. P. Enhanced transfection of tumor cells in vivo using Smart pH-sensitive TAT-modified pegylated liposomes J. Drug Targeting 2007, 15, 538-545
244. Apte, A.; Koren, E.; Koshkaryev, A.; Torchilin, V. P. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models Cancer Biol. Ther. 2014, 15, 69-80
245. Watarai, S.; Iwase, T.; Tajima, T.; Yuba, E.; Kono, K.; Sekiya, Y. Application of pH-sensitive fusogenic polymer-modified liposomes for development of mucosal vaccines Vet. Immunol. Immunopathol. 2014, 158, 62-72
246. Andresen, T. L.; Jensen, S. S.; Jorgensen, K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog. Lipid Res. 2005, 44, 68-97
247. Connor, J.; Huang, L. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes J. Cell Biol. 1985, 101, 582-589
248. Deshpande, P. P.; Biswas, S.; Torchilin, V. P. Current trends in the use of liposomes for tumor targeting Nanomedicine (London, U.K.) 2013, 8, 1509-1528
249. Farhood, H.; Serbina, N.; Huang, L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer Biochim. Biophys. Acta 1995, 1235, 289-295
250. Chen, Y.; Sun, J.; Lu, Y.; Tao, C.; Huang, J.; Zhang, H.; Yu, Y.; Zou, H.; Gao, J.; Zhong, Y. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors Int. J. Nanomed. 2013, 8, 1573-1593
251. Guo, X.; Gagne, L.; Chen, H.; Szoka, F. C. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo J. Liposome Res. 2014, 24, 90-98
252. Mo, R.; Sun, Q.; Li, N.; Zhang, C. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids Biomaterials 2013, 34, 2773-2786
253. Wang, X.; Liang, J.; Koike, T.; Sun, H.; Ichikawa, T.; Kitajima, S.; Morimoto, M.; Shikama, H.; Watanabe, T.; Sasaguri, Y.; Fan, J. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits Am. J. Pathol. 2004, 165, 1375-1383
254. Morko, J.; Kiviranta, R.; Joronen, K.; Saamanen, A. M.; Vuorio, E.; Salminen-Mankonen, H. Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K Arthritis Rheum. 2005, 52, 3713-3717
255. Niederer, F.; Ospelt, C.; Brentano, F.; Hottiger, M. O.; Gay, R. E.; Gay, S.; Detmar, M.; Kyburz, D. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance Ann. Rheum. Dis. 2011, 70, 1866-1873
256. Batist, G.; Tulpule, A.; Sinha, B. K.; Katki, A. G.; Myers, C. E.; Cowan, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J. Biol. Chem. 1986, 261, 15544-15549
257. Wan, Y.; Han, J.; Fan, G.; Zhang, Z.; Gong, T.; Sun, X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity Biomaterials 2013, 34, 3020-3030
258. Terada, T.; Iwai, M.; Kawakami, S.; Yamashita, F.; Hashida, M. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting J. Controlled Release 2006, 111, 333-342
259. Hatakeyama, H.; Akita, H.; Ishida, E.; Hashimoto, K.; Kobayashi, H.; Aoki, T.; Yasuda, J.; Obata, K.; Kikuchi, H.; Ishida, T.; Kiwada, H.; Harashima, H. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes Int. J. Pharm. 2007, 342, 194-200
260. Wust, P.; Hildebrandt, B.; Sreenivasa, G.; Rau, B.; Gellermann, J.; Riess, H.; Felix, R.; Schlag, P. M. Hyperthermia in combined treatment of cancer Lancet Oncol. 2002, 3, 487-497
261. Ben-Yosef, R. Hyperthermia combined with radiation therapy in the treatment of cancer patients Harefuah 2002, 141, 500
262. Landon, C. D.; Park, J. Y.; Needham, D.; Dewhirst, M. W. Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer Open Nanomed. J. 2011, 3, 38-64
263. Mills, J. K.; Needham, D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition Biochim. Biophys. Acta 2005, 1716, 77-96
264. Wood, B.; Poon, R.; Neeman, Z.; Eugeni, M.; Locklin, J.; Dromi, S.; Kachala, S.; Probhakar, R.; Hahne, W.; Libutti, S. Phase I study of thermally sensitive liposomes containing doxorubicin (ThermoDox) given during radiofrequency ablation (RFA) in patients with unresectable hepatic malignancies. Gastrointestinal Cancers Symposium; The American Society of Clinical Oncology: Orlando, FL, 19-21 January, 2007.
265. Tak, W.; Lin, S.; Wang, Y.; Zheng, J.; Izzo, F.; Park, S.; Chen, M.; Wong, S.; Xu, R.; Peng, C. Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA)+ lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cm. The 7th Annual Conference of the International Liver Cancer Association (ILCA); Washington, DC, 13-15 September, 2013, 2014; p 16.
266. Needham, D.; Anyarambhatla, G.; Kong, G.; Dewhirst, M. W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 2000, 60, 1197-1201
267. Chiu, G. N.; Abraham, S. A.; Ickenstein, L. M.; Ng, R.; Karlsson, G.; Edwards, K.; Wasan, E. K.; Bally, M. B. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese J. Controlled Release 2005, 104, 271-288
268. Banno, B.; Ickenstein, L. M.; Chiu, G. N.; Bally, M. B.; Thewalt, J.; Brief, E.; Wasan, E. K. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo J. Pharm. Sci. 2010, 99, 2295-2308
269. Tagami, T.; May, J. P.; Ernsting, M. J.; Li, S. D. A thermosensitive liposome prepared with a Cu(2)(+) gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy J. Controlled Release 2012, 161, 142-149
270. Tagami, T.; Foltz, W. D.; Ernsting, M. J.; Lee, C. M.; Tannock, I. F.; May, J. P.; Li, S. D. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome Biomaterials 2011, 32, 6570-6578
271. Tagami, T.; Ernsting, M. J.; Li, S. D. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin J. Controlled Release 2011, 152, 303-309
272. Chen, J.; He, C. Q.; Lin, A. H.; Gu, W.; Chen, Z. P.; Li, W.; Cai, B. C. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor Int. J. Pharm. 2014, 475, 408-415
273. Dicheva, B. M.; Ten Hagen, T. L.; Schipper, D.; Seynhaeve, A. L.; van Rhoon, G. C.; Eggermont, A. M.; Koning, G. A. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes J. Controlled Release 2014, 195, 37-48
274. Chen, K. J.; Chaung, E. Y.; Wey, S. P.; Lin, K. J.; Cheng, F.; Lin, C. C.; Liu, H. L.; Tseng, H. W.; Liu, C. P.; Wei, M. C.; Liu, C. M.; Sung, H. W. Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy ACS Nano 2014, 8, 5105-5115
275. Ward, M. A.; Georgiou, T. K. Thermoresponsive polymers for biomedical applications Polymers 2011, 3, 1215-1242
276. Kono, K. Thermosensitive polymer-modified liposomes Adv. Drug Delivery Rev. 2001, 53, 307-319
277. Matanovic, M. R.; Kristl, J.; Grabnar, P. A. Thermoresponsive polymers: insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications Int. J. Pharm. 2014, 472, 262-275
278. Ta, T.; Porter, T. M. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy J. Controlled Release 2013, 169, 112-125
279. Li, L.; ten Hagen, T. L.; Haeri, A.; Soullie, T.; Scholten, C.; Seynhaeve, A. L.; Eggermont, A. M.; Koning, G. A. A novel two-step mild hyperthermia for advanced liposomal chemotherapy J. Controlled Release 2014, 174, 202-208
280. Ng, K. Y.; Matsunaga, T. O. Ultrasound mediated drug delivery. Drug Delivery: Principles and Applications; John Wiley & Sons, Inc.: New York, 2005; Vol. 1, pp 245-278.
281. Paul, S.; Nahire, R.; Mallik, S.; Sarkar, K. Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery Comput. Mech. 2014, 53, 413-435
282. Park, E. J.; Zhang, Y. Z.; Vykhodtseva, N.; McDannold, N. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model J. Controlled Release 2012, 163, 277-284
283. Nomikou, N.; Li, Y. S.; McHale, A. P. Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy Cancer Lett. 2010, 288, 94-98
284. Evjen, T. J.; Nilssen, E. A.; Fowler, R. A.; Rognvaldsson, S.; Brandl, M.; Fossheim, S. L. Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound Int. J. Pharm. 2011, 406, 114-116
285. Lin, H. Y.; Thomas, J. L. Factors affecting responsivity of unilamellar liposomes to 20 kHz ultrasound Langmuir 2004, 20, 6100-6106
286. Buchanan, K. D.; Huang, S. L.; Kim, H.; McPherson, D. D.; MacDonald, R. C. Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release J. Controlled Release 2010, 141, 193-198
287. Kopechek, J. A.; Haworth, K. J.; Radhakrishnan, K.; Huang, S. L.; Klegerman, M. E.; McPherson, D. D.; Holland, C. K. The impact of bubbles on measurement of drug release from echogenic liposomes Ultrason. Sonochem. 2013, 20, 1121-1130
288. Kandadai, M. A.; Meunier, J. M.; Hart, K.; Holland, C. K.; Shaw, G. J. Plasmin-Loaded Echogenic Liposomes for Ultrasound-Mediated Thrombolysis. Transl. Stroke Res. 2014.
289. Peng, T.; Zeng, N.; Migliati, E. R.; Moddy, M. R.; Klegerman, M. E.; Kim, H.; Yin, X.; Geng, Y.-J.; McPherson, D. D.; Aronowski, J. Xenon Delivery Into Subarachnoid Hemorrhage via Echogenic Liposomes Provides Long-Term Neuroprotection Circulation 2014, 130, A15737-A15737
290. Naji, A. K.; Peng, T.; Britton, G.; McPherson, D. D.; Klegerman, M. E. Ultrasound Enhancement of Bevacizumab Release from Echogenic Liposomes for Inhibition of Atheroma Progression Arterioscler., Thromb., Vasc. Biol. 2014, 34, A263-A263
291. Molinari, F.; Meiburger, K. M.; Giustetto, P.; Rizzitelli, S.; Boffa, C.; Castano, M.; Terreno, E. Quantitative assessment of cancer vascular architecture by skeletonization of high-resolution 3-D contrast-enhanced ultrasound images: role of liposomes and microbubbles Technol. Cancer Res. Treat. 2014, 13, 541-550
292. Lee, S. Y.; Rim, Y.; McPherson, D. D.; Huang, S. L.; Kim, H. A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment Biomed. Mater. Eng. 2014, 24, 61-67
293. Deng, Z.; Yan, F.; Jin, Q.; Li, F.; Wu, J.; Liu, X.; Zheng, H. Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound J. Controlled Release 2014, 174, 109-116
294. Javadi, M.; Pitt, W. G.; Belnap, D. M.; Tsosie, N. H.; Hartley, J. M. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery Langmuir 2012, 28, 14720-14729
295. Javadi, M.; Pitt, W. G.; Tracy, C. M.; Barrow, J. R.; Willardson, B. M.; Hartley, J. M.; Tsosie, N. H. Ultrasonic gene and drug delivery using eLiposomes J. Controlled Release 2013, 167, 92-100
296. Lin, C. Y.; Javadi, M.; Belnap, D. M.; Barrow, J. R.; Pitt, W. G. Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy Nanomedicine 2014, 10, 67-76
297. Reimhult, E. Nanoparticle-triggered release from lipid membrane vesicles. N. Biotechnol. 2014.
298. Fattahi, H.; Laurent, S.; Liu, F.; Arsalani, N.; Vander Elst, L.; Muller, R. N. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics Nanomedicine (London, U.K.) 2011, 6, 529-544
299. Shubayev, V. I.; Pisanic, T. R., II; Jin, S. Magnetic nanoparticles for theragnostics Adv. Drug Delivery Rev. 2009, 61, 467-477
300. Nobuto, H.; Sugita, T.; Kubo, T.; Shimose, S.; Yasunaga, Y.; Murakami, T.; Ochi, M. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet Int. J. Cancer 2004, 109, 627-635
301. Nappini, S.; Bombelli, F. B.; Bonini, M.; Nordèn, B.; Baglioni, P. Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field Soft Matter 2010, 6, 154-162
302. Preiss, M. R.; Bothun, G. D. Stimuli-responsive liposome-nanoparticle assemblies Expert Opin. Drug Delivery 2011, 8, 1025-1040
303. Qiu, D.; An, X.; Chen, Z.; Ma, X. Microstructure study of liposomes decorated by hydrophobic magnetic nanoparticles Chem. Phys. Lipids 2012, 165, 563-570
304. Qiu, D.; An, X. Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation Colloids Surf., B 2013, 104, 326-329
305. Amstad, E.; Kohlbrecher, J.; Müller, E.; Schweizer, T.; Textor, M.; Reimhult, E. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes Nano Lett. 2011, 11, 1664-1670
306. Podaru, G.; Ogden, S.; Baxter, A.; Shrestha, T.; Ren, S.; Thapa, P.; Dani, R. K.; Wang, H.; Basel, M. T.; Prakash, P.; Bossmann, S. H.; Chikan, V. Pulsed magnetic field induced fast drug release from magneto liposomes via ultrasound generation J. Phys. Chem. B 2014, 118, 11715-11722
307. Floris, A.; Sinico, C.; Fadda, A. M.; Lai, F.; Marongiu, F.; Scano, A.; Pilloni, M.; Angius, F.; Vazquez-Vazquez, C.; Ennas, G. Characterization and cytotoxicity studies on liposome-hydrophobic magnetite hybrid colloids J. Colloid Interface Sci. 2014, 425, 118-127
308. Yavlovich, A.; Singh, A.; Blumenthal, R.; Puri, A. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells Biochim. Biophys. Acta 2011, 1808, 117-126
309. Zhu, L.; Torchilin, V. P. Stimulus-responsive nanopreparations for tumor targeting Integr. Biol. 2013, 5, 96-107
310. Bressler, N. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2 JAMA Ophthalmol. 2001, 119, 198-207
311. Zakaria, S.; Gamal-Eldeen, A. M.; El-Daly, S. M.; Saleh, S. Synergistic apoptotic effect of Doxil (R) and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells Photodiagn. Photodyn. Ther. 2014, 11, 227-238
312. Ta, T.; Bartolak-Suki, E.; Park, E. J.; Karrobi, K.; McDannold, N. J.; Porter, T. M. Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating J. Controlled Release 2014, 194, 71-81
313. Zhou, W.; An, X.; Wang, J.; Shen, W.; Chen, Z.; Wang, X. Characteristics, phase behavior and control release for copolymer-liposome with both pH and temperature sensitivities Colloids Surf., A 2012, 395, 225-232
314. Nahire, R.; Hossain, R.; Patel, R.; Paul, S.; Meghnani, V.; Ambre, A. H.; Gange, K. N.; Katti, K. S.; Leclerc, E.; Srivastava, D. K.; Sarkar, K.; Mallik, S. pH-triggered echogenicity and contents release from liposomes Mol. Pharmaceutics 2014, 11, 4059-4068
315. Matsumoto, Y.; Kato, T.; Iseki, S.; Suzuki, H.; Nakano, K.; Iwahara, M.; Ueoka, R. Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells Bioorg. Med. Chem. Lett. 1999, 9, 1937-1940
316. Matsumoto, Y.; Iwamoto, Y.; Matsushita, T.; Ueoka, R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells Int. J. Cancer 2005, 115, 377-382
317. Komizu, Y.; Matsumoto, Y.; Ueoka, R. Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis Bioorg. Med. Chem. Lett. 2006, 16, 6131-6134
318. Ichihara, H.; Matsumoto, Y.; Ueoka, R. Chemotherapy and Detection of Cancer Using Hybrid Liposomes; World Automation Congress (WAC): Waikoloa, HI, 2014; pp 125-130.
319. Kitajima, H.; Komizu, Y.; Ichihara, H.; Goto, K.; Ueoka, R. Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells Cancer Med. 2013, 2, 267-276
320. Ichihara, H.; Nagami, H.; Kiyokawa, T.; Matsumoto, Y.; Ueoka, R. Chemotherapy using hybrid liposomes along with induction of apoptosis Anticancer Res. 2008, 28, 1187-1195
321. Nagami, H.; Matsumoto, Y.; Ueoka, R. Chemotherapy with hybrid liposomes for lymphoma without drugs in vivo Int. J. Pharm. 2006, 315, 167-172
322. Ichihara, H.; Nakagawa, S.; Matsuoka, Y.; Yoshida, K.; Matsumoto, Y.; Ueoka, R. Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo Anticancer Res. 2014, 34, 4701-4708
323. Kitamura, I.; Kochi, M.; Matsumoto, Y.; Ueoka, R.; Kuratsu, J.; Ushio, Y. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study Cancer Res. 1996, 56, 3986-3992
324. Matsumoto, Y.; Cao, E.; Ueoka, R. Novel liposomes composed of dimyristoylphosphatidylcholine and trehalose surfactants inhibit the growth of tumor cells along with apoptosis Biol. Pharm. Bull. 2013, 36, 1258-1262
325. Le Meins, J.-F.; Schatz, C.; Lecommandoux, S.; Sandre, O. Hybrid polymer/lipid vesicles: state of the art and future perspectives Mater. Today 2013, 16, 397-402
326. Gao, L.-Y.; Liu, X.-Y.; Chen, C.-J.; Wang, J.-C.; Feng, Q.; Yu, M.-Z.; Ma, X.-F.; Pei, X.-W.; Niu, Y.-J.; Qiu, C. Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery Biomaterials 2014, 35, 2066-2078
327. Yang, Z.; Luo, X.; Zhang, X.; Liu, J.; Jiang, Q. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles Biomed. Mater. 2013, 8, 025012
328. Shen, W.; Hu, J.; Hu, X. Impact of amphiphilic triblock copolymers on stability and permeability of phospholipid/polymer hybrid vesicles Chem. Phys. Lett. 2014, 600, 56-61
329. Lim, S. K.; de Hoog, H.-P.; Parikh, A. N.; Nallani, M.; Liedberg, B. Hybrid, Nanoscale Phospholipid/Block Copolymer Vesicles Polymers 2013, 5, 1102-1114
330. Quinteros, D.; Vicario-de-la-Torre, M.; Andres-Guerrero, V.; Palma, S.; Allemandi, D.; Herrero-Vanrell, R.; Molina-Martinez, I. T. Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes PLoS One 2014, 9, e110344
331. Nam, J.; Ha, Y. S.; Hwang, S.; Lee, W.; Song, J.; Yoo, J.; Kim, S. pH-responsive gold nanoparticles-in-liposome hybrid nanostructures for enhanced systemic tumor delivery Nanoscale 2013, 5, 10175-10178
332. Stiufiuc, R.; Iacovita, C.; Stiufiuc, G.; Florea, A.; Achim, M.; Lucaciu, C. M. A new class of pegylated plasmonic liposomes: Synthesis and characterization J. Colloid Interface Sci. 2015, 437, 17-23
333. Tan, S.; Li, X.; Guo, Y.; Zhang, Z. Lipid-enveloped hybrid nanoparticles for drug delivery Nanoscale 2013, 5, 860-872
334. Sur, S.; Fries, A. C.; Kinzler, K. W.; Zhou, S.; Vogelstein, B. Remote loading of preencapsulated drugs into stealth liposomes Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 2283-2288
335. Matloob, A. H.; Mourtas, S.; Klepetsanis, P.; Antimisiaris, S. G. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: A comparative study Int. J. Pharm. 2014, 476, 108-115
336. Tian, B.; Kostarelos, K. The engineering of doxorubicin-loaded liposome-quantum dot hybrids for cancer theranostics Chin. Phys. B 2014, 23, 087805
337. Narsaiah, K.; Jha, S.; Wilson, R. A.; Mandge, H.; Manikantan, M.; Malik, R.; Vij, S. Pediocin-Loaded Nanoliposomes and Hybrid Alginate-Nanoliposome Delivery Systems for Slow Release of Pediocin BioNanoScience 2013, 3, 37-42
338. Petralito, S.; Spera, R.; Pacelli, S.; Relucenti, M.; Familiari, G.; Vitalone, A.; Paolicelli, P.; Casadei, M. A. Design and development of PEG-DMA gel-in-liposomes as a new tool for drug delivery React. Funct. Polym. 2014, 77, 30-38
339. Pierre, M. B.; Dos Santos Miranda Costa, I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications Arch. Dermatol. Res. 2011, 303, 607-621
340. Rahimpour, Y.; Hamishehkar, H. Liposomes in cosmeceutics Expert Opin. Drug Delivery 2012, 9, 443-455
341. Goel, A.; Baboota, S.; Sahni, J. K.; Ali, J. Exploring targeted pulmonary delivery for treatment of lung cancer Int. J. Pharm. Invest. 2013, 3, 8-14
342. Andrade, F.; Rafael, D.; Videira, M.; Ferreira, D.; Sosnik, A.; Sarmento, B. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases Adv. Drug Delivery Rev. 2013, 65, 1816-1827
343. Jaafar-Maalej, C.; Elaissari, A.; Fessi, H. Lipid-based carriers: manufacturing and applications for pulmonary route Expert Opin. Drug Delivery 2012, 9, 1111-1127
344. Fricker, G.; Kromp, T.; Wendel, A.; Blume, A.; Zirkel, J.; Rebmann, H.; Setzer, C.; Quinkert, R. O.; Martin, F.; Muller-Goymann, C. Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 2010, 27, 1469-1486
345. Mei, L.; Zhang, Z.; Zhao, L.; Huang, L.; Yang, X. L.; Tang, J.; Feng, S. S. Pharmaceutical nanotechnology for oral delivery of anticancer drugs Adv. Drug Delivery Rev. 2013, 65, 880-890
346. Thanki, K.; Gangwal, R. P.; Sangamwar, A. T.; Jain, S. Oral delivery of anticancer drugs: challenges and opportunities J. Controlled Release 2013, 170, 15-40
347. Tamaru, M.; Akita, H.; Kajimoto, K.; Sato, Y.; Hatakeyama, H.; Harashima, H. An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells Int. J. Pharm. 2014, 465, 77-82
348. Bao, Q. Y.; Zhang, N.; Geng, D. D.; Xue, J. W.; Merritt, M.; Zhang, C.; Ding, Y. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles Int. J. Pharm. 2014, 477, 408-415
349. Wang, J.; Jia, J.; Liu, J.; He, H.; Zhang, W.; Li, Z. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins Drug Delivery 2013, 20, 356-363
350. Li, X. Y.; Zhao, Y.; Sun, M. G.; Shi, J. F.; Ju, R. J.; Zhang, C. X.; Li, X. T.; Zhao, W. Y.; Mu, L. M.; Zeng, F.; Lou, J. N.; Lu, W. L. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma Biomaterials 2014, 35, 5591-5604
351. Yin, Y.; Wu, X.; Yang, Z.; Zhao, J.; Wang, X.; Zhang, Q.; Yuan, M.; Xie, L.; Liu, H.; He, Q. The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension Pharm. Res. 2013, 30, 2050-2062
352. Baek, S. E.; Lee, K. H.; Park, Y. S.; Oh, D. K.; Oh, S.; Kim, K. S.; Kim, D. E. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo J. Controlled Release 2014, 196, 234-242
353. Yan, Z.; Wang, F.; Wen, Z.; Zhan, C.; Feng, L.; Liu, Y.; Wei, X.; Xie, C.; Lu, W. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor J. Controlled Release 2012, 157, 118-125
354. Zong, T.; Mei, L.; Gao, H.; Cai, W.; Zhu, P.; Shi, K.; Chen, J.; Wang, Y.; Gao, F.; He, Q. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals Mol. Pharmaceutics 2014, 11, 2346-2357
355. Wang, C.; Feng, L.; Yang, X.; Wang, F.; Lu, W. Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy Asian J. Pharm. Sci. 2013, 8, 118-127
356. Zhong, J.; Mao, W.; Shi, R.; Jiang, P.; Wang, Q.; Zhu, R.; Wang, T.; Ma, Y. Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogs Cancer Chemother. Pharmacol. 2014, 73, 459-466
357. Qu, B.; Li, X.; Guan, M.; Li, X.; Hai, L.; Wu, Y. Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes Eur. J. Med. Chem. 2014, 72, 110-118
358. Qu, M. H.; Zeng, R. F.; Fang, S.; Dai, Q. S.; Li, H. P.; Long, J. T. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer Int. J. Pharm. 2014, 474, 112-122
359. Yang, Z. Z.; Li, J. Q.; Wang, Z. Z.; Dong, D. W.; Qi, X. R. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas Biomaterials 2014, 35, 5226-5239
360. Peddada, L. Y.; Garbuzenko, O. B.; Devore, D. I.; Minko, T.; Roth, C. M. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes J. Controlled Release 2014, 194, 103-112
361. Shen, H.; Rodriguez-Aguayo, C.; Xu, R.; Gonzalez-Villasana, V.; Mai, J.; Huang, Y.; Zhang, G.; Guo, X.; Bai, L.; Qin, G.; Deng, X.; Li, Q.; Erm, D. R.; Aslan, B.; Liu, X.; Sakamoto, J.; Chavez-Reyes, A.; Han, H. D.; Sood, A. K.; Ferrari, M.; Lopez-Berestein, G. Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery Clin. Cancer Res. 2013, 19, 1806-1815
362. Tsujiuchi, T.; Natsume, A.; Motomura, K.; Kondo, G.; Ranjit, M.; Hachisu, R.; Sugimura, I.; Tomita, S.; Takehara, I.; Woolley, M.; Barua, N. U.; Gill, S. S.; Bienemann, A. S.; Yamashita, Y.; Toyokuni, S.; Wakabayashi, T. Preclinical evaluation of an O(6)-methylguanine-DNA methyltransferase-siRNA/liposome complex administered by convection-enhanced delivery to rat and porcine brains Am. J. Transl. Res. 2014, 6, 169-178
363. Yuba, E.; Harada, A.; Sakanishi, Y.; Watarai, S.; Kono, K. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy Biomaterials 2013, 34, 3042-3052
364. Miyabe, H.; Hyodo, M.; Nakamura, T.; Sato, Y.; Hayakawa, Y.; Harashima, H. A new adjuvant delivery system cyclic di-GMP/YSK05 liposome' for cancer immunotherapy J. Controlled Release 2014, 184, 20-27
365. Song, J. M.; Kirtane, A. R.; Upadhyaya, P.; Qian, X.; Balbo, S.; Teferi, F.; Panyam, J.; Kassie, F. Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability Int. J. Pharm. 2014, 477, 96-101
366. Hamblin, K. A.; Wong, J. P.; Blanchard, J. D.; Atkins, H. S. The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy Front. Cell. Infect. Microbiol. 2014, 4, 79
367. Marques, J.; Moles, E.; Urban, P.; Prohens, R.; Busquets, M. A.; Sevrin, C.; Grandfils, C.; Fernandez-Busquets, X. Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells Nanomedicine 2014, 10, 1719-1728
368. Guo, J.; Waknine-Grinberg, J. H.; Mitchell, A. J.; Barenholz, Y.; Golenser, J. Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based beta-methasone nanodrug Biomed. Res. Int. 2014, 2014, 292471
369. Waknine-Grinberg, J. H.; Even-Chen, S.; Avichzer, J.; Turjeman, K.; Bentura-Marciano, A.; Haynes, R. K.; Weiss, L.; Allon, N.; Ovadia, H.; Golenser, J.; Barenholz, Y. Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria PLoS One 2013, 8, e72722
370. Bhardwaj, A.; Kumar, L.; Narang, R. K.; Murthy, R. S. Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis Artif. Cells, Nanomed., Biotechnol. 2013, 41, 52-59
371. Rojanarat, W.; Nakpheng, T.; Thawithong, E.; Yanyium, N.; Srichana, T. Inhaled pyrazinamide proliposome for targeting alveolar macrophages Drug. Delivery 2012, 19, 334-345
372. Rojanarat, W.; Nakpheng, T.; Thawithong, E.; Yanyium, N.; Srichana, T. Levofloxacin-proliposomes: opportunities for use in lung tuberculosis Pharmaceutics 2012, 4, 385-412
373. Rose, S. J.; Neville, M. E.; Gupta, R.; Bermudez, L. E. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection PLoS One 2014, 9, e108703
374. Ivanova, V.; Garbuzenko, O. B.; Reuhl, K. R.; Reimer, D. C.; Pozharov, V. P.; Minko, T. Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2 Eur. J. Pharm. Biopharm. 2013, 84, 335-344
375. Rousseau, N.; Picot, S.; Bienvenu, A. L. Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice Front. Immunol. 2014, 5, 502
376. Yanamandra, S.; Venkatesan, N.; Kadajji, V. G.; Wang, Z.; Issar, M.; Betageri, G. V. Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: case study using a model drug Eur. J. Pharm. Sci. 2014, 64, 26-36
377. Niu, M.; Tan, Y.; Guan, P.; Hovgaard, L.; Lu, Y.; Qi, J.; Lian, R.; Li, X.; Wu, W. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study Int. J. Pharm. 2014, 460, 119-130
378. Zhang, X.; Qi, J.; Lu, Y.; He, W.; Li, X.; Wu, W. Biotinylated liposomes as potential carriers for the oral delivery of insulin Nanomedicine 2014, 10, 167-176
379. Gradauer, K.; Barthelmes, J.; Vonach, C.; Almer, G.; Mangge, H.; Teubl, B.; Roblegg, E.; Dunnhaupt, S.; Frohlich, E.; Bernkop-Schnurch, A.; Prassl, R. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats J. Controlled Release 2013, 172, 872-878
380. Gangishetty, H.; Eedara, B. B.; Bandari, S. Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation Pharm. Dev. Technol. 2014, 1-11
381. Zhao, Y. Z.; Lu, C. T.; Zhang, Y.; Xiao, J.; Zhao, Y. P.; Tian, J. L.; Xu, Y. Y.; Feng, Z. G.; Xu, C. Y. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery Int. J. Pharm. 2013, 454, 302-309
382. Caddeo, C.; Sales, O. D.; Valenti, D.; Sauri, A. R.; Fadda, A. M.; Manconi, M. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs Int. J. Pharm. 2013, 443, 128-136
383. Wang, Y.; Su, W.; Li, Q.; Li, C.; Wang, H.; Li, Y.; Cao, Y.; Chang, J.; Zhang, L. Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery Int. J. Pharm. 2013, 441, 748-756
384. Zhang, Y. T.; Shen, L. N.; Wu, Z. H.; Zhao, J. H.; Feng, N. P. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy Int. J. Pharm. 2014, 471, 449-452
385. Silindir, M.; Erdogan, S.; Ozer, A. Y.; Maia, S. Liposomes and their applications in molecular imaging J. Drug Targeting 2012, 20, 401-415
386. Bao, A.; Goins, B.; Klipper, R.; Negrete, G.; Phillips, W. T. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies J. Pharmacol. Exp. Ther. 2004, 308, 419-425
387. Li, S.; Goins, B.; Phillips, W. T.; Bao, A. Remote-loading labeling of liposomes with (99m)Tc-BMEDA and its stability evaluation: effects of lipid formulation and pH/chemical gradient J. Liposome Res. 2011, 21, 17-27
388. Erdogan, S.; Medarova, Z. O.; Roby, A.; Moore, A.; Torchilin, V. P. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes J. Magn. Reson. Imaging 2008, 27, 574-580
389. Cheng, Z.; Al Zaki, A.; Jones, I. W.; Hall, H. K., Jr.; Aspinwall, C. A.; Tsourkas, A. Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent Chem. Commun. (Cambridge, U.K.) 2014, 50, 2502-2504
390. Murata, M.; Tahara, K.; Takeuchi, H. Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration Eur. J. Pharm. Biopharm. 2014, 86, 115-119
391. Vallabhajosula, S. Molecular Imaging: Radiopharmaceuticals for PET and SPECT; Springer-Verlag: Heidelberg, Germany, 2009; http://www.springer.com/us/book/9783540767350.
392. Rahmim, A.; Zaidi, H. PET versus SPECT: strengths, limitations and challenges Nucl. Med. Commun. 2008, 29, 193-207
393. Muthu, M. S.; Feng, S. S. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success Expert Opin. Drug Delivery 2013, 10, 151-155
394. Ryu, J. H.; Koo, H.; Sun, I. C.; Yuk, S. H.; Choi, K.; Kim, K.; Kwon, I. C. Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy Adv. Drug Delivery Rev. 2012, 64, 1447-1458
395. Arrieta, O.; Medina, L.-A.; Estrada-Lobato, E.; Ramírez-Tirado, L.-A.; Mendoza-García, V.-O.; de la Garza-Salazar, J. High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin Cancer Chemother. Pharmacol. 2014, 1-5
396. Allison, A. G.; Gregoriadis, G. Liposomes as immunological adjuvants Nature 1974, 252, 252
397. Alving, C. R. Liposomes as carriers of antigens and adjuvants J. Immunol. Methods 1991, 140, 1-13
398. Watson, D. S.; Endsley, A. N.; Huang, L. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens Vaccine 2012, 30, 2256-2272
399. Schwendener, R. A. Liposomes as vaccine delivery systems: a review of the recent advances Ther. Adv. Vaccines 2014, 2, 159-182
400. Hussain, M. J.; Wilkinson, A.; Bramwell, V. W.; Christensen, D.; Perrie, Y. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants J. Pharm. Pharmacol. 2014, 66, 358-366
401. van Dissel, J. T.; Joosten, S. A.; Hoff, S. T.; Soonawala, D.; Prins, C.; Hokey, D. A.; O'Dee, D. M.; Graves, A.; Thierry-Carstensen, B.; Andreasen, L. V.; Ruhwald, M.; de Visser, A. W.; Agger, E. M.; Ottenhoff, T. H.; Kromann, I.; Andersen, P. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Vaccine 2014, 32, 7098-7107
402. Pang, Y.; Zhang, Y.; Wang, H.; Jin, J.; Piao, J.; Piao, J.; Liu, Q.; Li, W. Reduction of Salmonella enteritidis number after infections by immunization of liposome-associated recombinant SefA Avian Dis. 2013, 57, 627-633
403. Takagi, A.; Kobayashi, N.; Taneichi, M.; Uchida, T.; Akatsuka, T. Coupling to the surface of liposomes alters the immunogenicity of hepatitis C virus-derived peptides and confers sterile immunity Biochem. Biophys. Res. Commun. 2013, 430, 183-189
404. Pichon, C.; Midoux, P. Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA Methods Mol. Biol. 2013, 969, 247-274
405. Amidi, M.; van Helden, M. J.; Tabataei, N. R.; de Goede, A. L.; Schouten, M.; de Bot, V.; Lanzi, A.; Gruters, R. A.; Rimmelzwaan, G. F.; Sijts, A. J.; Mastrobattista, E. Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes J. Controlled Release 2012, 164, 323-330
406. Guan, H. H.; Budzynski, W.; Koganty, R. R.; Krantz, M. J.; Reddish, M. A.; Rogers, J. A.; Longenecker, B. M.; Samuel, J. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses Bioconjugate Chem. 1998, 9, 451-458
407. Gramatica, A.; Petazzi, R. A.; Lehmann, M. J.; Ziomkowska, J.; Herrmann, A.; Chiantia, S. alphaEnv-decorated phosphatidylserine liposomes trigger phagocytosis of HIV-virus-like particles in macrophages Nanomedicine 2014, 10, 981-989
408. Wang, C.; Liu, P.; Zhuang, Y.; Li, P.; Jiang, B.; Pan, H.; Liu, L.; Cai, L.; Ma, Y. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory Vaccine 2014, 32, 5475-5483
409. Christensen, D.; Korsholm, K. S.; Agger, E. M.; Andersen, P. Modified cationic liposome adjuvants. U.S. Patent US20140205656 A1, Jul 24, 2014.
410. Matyas, G. R.; Mayorov, A. V.; Rice, K. C.; Jacobson, A. E.; Cheng, K.; Iyer, M. R.; Li, F.; Beck, Z.; Janda, K. D.; Alving, C. R. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs Vaccine 2013, 31, 2804-2810
411. Henriksen-Lacey, M.; Perrie, Y. Designing Liposomes as Vaccine Adjuvants. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines; Springer: New York, 2013; pp 181-203.
412. Varypataki, E. M.; van der Maaden, K.; Bouwstra, J.; Ossendorp, F.; Jiskoot, W. Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity. AAPS J. 2014.
413. Chang, H. I.; Yeh, M. K. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy Int. J. Nanomed. 2012, 7, 49-60
414. Kroemer, G.; Zitvogel, L.; Galluzzi, L. Victories and deceptions in tumor immunology: Stimuvax Oncoimmunology 2013, 2, e23687
415. Liu, Q.; Boyd, B. J. Liposomes in biosensors Analyst 2013, 138, 391-409
416. Gómez-Hens, A.; Manuel Fernández-Romero, J. The role of liposomes in analytical processes Trends Anal. Chem. 2005, 24, 9-19
417. Edwards, K. A.; Baeumner, A. J. Liposomes in analyses Talanta 2006, 68, 1421-1431
418. Edwards, K. A.; Baeumner, A. J. Periplasmic binding protein-based detection of maltose using liposomes: a new class of biorecognition elements in competitive assays Anal. Chem. 2013, 85, 2770-2778
419. Tien, C. Y.; Jou, A. F. j.; Fan, N. C.; Chuang, M. C.; Ho, J. a. A. Preparation of Liposomal Progesterone and Its Application on the Measurement of Progesterone Interpreted via Electrochemical and Colorimetric Sensing Platforms Electroanalysis 2013, 25, 1017-1022
420. Wallner, J.; Lhota, G.; Jeschek, D.; Mader, A.; Vorauer-Uhl, K. Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions J. Pharm. Biomed. Anal. 2013, 72, 150-154
421. Bilek, G.; Weiss, V. U.; Pickl-Herk, A.; Blaas, D.; Kenndler, E. Chip electrophoretic characterization of liposomes with biological lipid composition: Coming closer to a model for viral infection Electrophoresis 2009, 30, 4292-4299
422. Boija, E.; Lundquist, A.; Martinez Pla, J. J.; Engvall, C.; Lundahl, P. Effects of ions and detergents in drug partition chromatography on liposomes J. Chromatogr., A 2004, 1030, 273-278
423. Liu, X. Y.; Yang, Q.; Kamo, N.; Miyake, J. Effect of liposome type and membrane fluidity on drug-membrane partitioning analyzed by immobilized liposome chromatography J. Chromatogr., A 2001, 913, 123-131
424. Lundin, M. Nanomedicine Market, 2013; http://www.bionanonet.at/images/nanomedicine.pdf, Dec. 30, 2014.
425. Ehmann, F.; Sakai-Kato, K.; Duncan, R.; Hernan Perez de la Ossa, D.; Pita, R.; Vidal, J. M.; Kohli, A.; Tothfalusi, L.; Sanh, A.; Tinton, S.; Robert, J. L.; Silva Lima, B.; Amati, M. P. Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines Nanomedicine (London, U.K.) 2013, 8, 849-856
426. Bawa, R. 41 FDA and Nanotech: Baby Steps Lead to Regulatory Uncertainty, 2013; http://bawabiotech.com/uploads/Dr.-Bawa-FDA-and-Nanotech-2013-.pdf, Dec. 30, 2014.
427. Sadrieh, N.; Tyner, K. M. Nanotechnology and therapeutic delivery: a drug regulation perspective Ther. Delivery 2010, 1, 83-89
428. Smistad, G.; Jacobsen, J.; Sande, S. A. Multivariate toxicity screening of liposomal formulations on a human buccal cell line Int. J. Pharm. 2007, 330, 14-22
429. Alhajlan, M.; Alhariri, M.; Omri, A. Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors Antimicrob. Agents Chemother. 2013, 57, 2694-2704
430. Dokka, S.; Toledo, D.; Shi, X.; Castranova, V.; Rojanasakul, Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes Pharm. Res. 2000, 17, 521-525